SCHEMBL27392018

SCHEMBL27392018

CCS(=O)(=O)c1ccc(Oc2ccc(CCC3CCNCC3)nc2)c(-c2cn(C)c(=O)c3[nH]ccc23)c1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30824799 1.00 BRD4 (0.63) BRD4
SCHEMBL31748104 0.91 BRD4 (0.62) BRD4
SCHEMBL27392016 0.87 BRD4 (0.70) BRD4
SCHEMBL27392576 0.84 BRD4 (0.57) BRD4
SCHEMBL27390739 0.83 BRD4 (0.69) BRD4
SCHEMBL30824893 0.83 BRD4 (0.69) BRD4
SCHEMBL27392098 0.83 BRD4 (0.71) BRD4
SCHEMBL30824774 0.83 BRD4 (0.71) BRD4
SCHEMBL30812024 0.82 BRD4 (0.54) BRD4
SCHEMBL30812158 0.79 BRD4 (0.47) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054955-A1 HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2024-03-14 — — WO disclosed
Send feedback